Abnormalities in biliary drainage may predict a better response to ursodeoxycholic acid in cystic fibrosis-associated liver disease.

被引：0
|
作者：
Colombo, C
Castellani, MR
Crosignani, A
Comi, S
Giunta, A
机构：
[1] UNIV SASSARI,DEPT PEDIAT,I-07100 SASSARI,ITALY
[2] UNIV MILAN,DEPT PEDIAT,I-20122 MILAN,ITALY
[3] UNIV MILAN,DEPT INTERNAL MED,I-20122 MILAN,ITALY
[4] IST NAZL TUMORI,DEPT NUCL MED,I-20133 MILAN,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：298 / 298
页数：1
相关论文
共 50 条
  • [1] Ursodeoxycholic acid in cystic fibrosis-associated liver disease Response
    Colombo, Carla
    Debray, Dominique
    Kelly, Deirdre
    Houwen, Roderick
    Battezzati, Pier Maria
    Strandvik, Birgitta
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 74 - 75
  • [2] Ursodeoxycholic acid in cystic fibrosis-associated liver disease
    Ooi, Chee Y.
    Nightingale, Scott
    Durie, Peter R.
    Freedman, Steven D.
    JOURNAL OF CYSTIC FIBROSIS, 2012, 11 (01) : 72 - 73
  • [3] Ursodeoxycholic acid treatment in cystic fibrosis-associated liver disease
    Colombo, C
    Comi, S
    Moretti, E
    BIOLOGY OF BILE ACIDS IN HEALTH AND DISEASE, 2001, 120 : 311 - 316
  • [4] URSODEOXYCHOLIC ACID FOR CYSTIC FIBROSIS-ASSOCIATED LIVER-DISEASE - FINAL REPORT OF A MULTICENTER TRIAL
    COLOMBO, C
    PODDA, M
    BATTEZZATI, PM
    SANTINI, B
    IAPICHINO, L
    QUATTRUCCI, S
    LUCIDI, V
    FERRARI, R
    SCOTTA, S
    MINICUCCI, L
    CANDUSSO, M
    VALLETTA, E
    GAGLIARDINI, R
    SANTAMARIA, F
    BATTISTINI, F
    GIUNTA, A
    HEPATOLOGY, 1993, 18 (04) : A142 - A142
  • [5] Cystic fibrosis-associated liver disease
    Herrmann, Ulrike
    Dockter, Gerd
    Lammert, Frank
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2010, 24 (05) : 585 - 592
  • [6] Markers of cystic fibrosis-associated liver disease
    Narkewicz, MR
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (04): : 421 - 422
  • [7] Cystic fibrosis-associated liver disease in children
    Wasuwanich, Paul
    Karnsakul, Wikrom
    MINERVA PEDIATRICA, 2020, 72 (05) : 440 - 447
  • [8] Delayed intestinal visualization at hepatobiliary scintigraphy is associated with response to long-term treatment with ursodeoxycholic acid in patients with cystic fibrosis-associated liver disease
    Colombo, C
    Crosignani, A
    Battezzati, PM
    Castellani, MR
    Comi, S
    Melzi, ML
    Giunta, A
    JOURNAL OF HEPATOLOGY, 1999, 31 (04) : 672 - 677
  • [9] A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease
    Lindblad, A
    Glaumann, H
    Strandvik, B
    HEPATOLOGY, 1998, 27 (01) : 166 - 174
  • [10] URSODEOXYCHOLIC ACID EFFECTS ON CYSTIC FIBROSIS LIVER DISEASE
    Ciuca, Ioana Mihaiela
    Pop, Liviu
    Ranetti, Aurelian Emil
    Popescu, Iuliana M.
    Almajan-Guta, Bogdan
    Malita, Ioana Maria
    Anghel, Ion
    FARMACIA, 2015, 63 (04) : 543 - 547
12345